Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares

The following table summarizes the calculation of weighted average common shares outstanding used in the computation of basic and diluted earnings per share (in thousands):

	Three Months Ended
	March 31,
	2023		2022
Weighted average common shares outstanding - basic		46,634		46,298
Effect of dilutive securities:
Restricted shares		105		—
Performance shares		742		—
Weighted average common shares outstanding - diluted		47,481		46,298

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the three months ended March 31, 2022, the number of outstanding performance and restricted shares of Core Laboratories N.V. common shares that were excluded from the diluted earnings per share calculation, as their impact would be antidilutive, were as follows (in thousands):

	Three Months Ended
	March 31, 2022
Restricted shares		146
Performance shares		818